Results 181 to 190 of about 5,816 (198)

A Henipavirus Vaccine in Sight

Science, 2012
A candidate vaccine against Nipah and Hendra viruses, recently emerging zoonotic threats, looks promising.
Veronika von Messling, Roberto Cattaneo
openaire   +1 more source

Profiling Host MicroRNA Responses to Henipavirus Infection

2023
Diseases caused by henipaviruses feature incubation periods of up to 16 days, during which infected animals may show no apparent signs of disease yet be capable of transmitting the virus to humans. This risk has prompted research into host-derived biomarkers for early disease detection. Here, we describe a methodology for the assaying of host microRNAs
Ryan J, Farr, Sudeep, Dahal, Leon, Tribolet, Andrew G D, Bean, Christopher, Cowled, Cameron R, Stewart   +5 more
openaire   +2 more sources

Animal models of henipavirus infection: A review

The Veterinary Journal, 2009
Hendra virus (HeV) and Nipah virus (NiV) form a separate genus Henipavirus within the family Paramyxoviridae, and are classified as biosafety level four pathogens due to their high case fatality rate following human infection and because of the lack of effective vaccines or therapy.
Hana M, Weingartl, Yohannes, Berhane, Markus, Czub   +2 more
openaire   +2 more sources

Epidemiology of Henipavirus Disease in Humans

2012
All seven recognized human cases of Hendra virus (HeV) infection have occurred in Queensland, Australia. Recognized human infections have all resulted from a HeV infected horse that was unusually efficient in transmitting the virus and a person with a high exposure to infectious secretions.
Stephen P, Luby, Emily S, Gurley
openaire   +2 more sources

Henipavirus Membrane Fusion and Viral Entry

2012
Nipah (NiV) and Hendra (HeV) viruses cause cell-cell fusion (syncytia) in brain, lung, heart, and kidney tissues, leading to encephalitis, pneumonia, and often death. Membrane fusion is essential to both viral entry and virus-induced cell-cell fusion, a hallmark of henipavirus infections.
Hector C, Aguilar, Ronald M, Iorio
openaire   +2 more sources

Langya henipavirus outbreak

Expert Review of Anti-infective Therapy, 2023
Vivek P Chavda, Vasso Apostolopoulos, Ranjit Sah   +2 more
openaire   +2 more sources

Infection and transmission of henipavirus in animals

Comparative Immunology, Microbiology and Infectious Diseases
Henipavirus (HNV) is well known for two zoonotic viruses in the genus, Hendra virus (HeV) and Nipah virus (NiV), which pose serious threat to human and animal health. In August 2022, a third zoonotic virus in the genus Henipavirus, Langya virus (LayV), was discovered in China.
Xinyu Qiu, Feng Wang, Ailong Sha
openaire   +2 more sources

Current Status of Diagnostic Methods for Henipavirus

2013
Hendra virus (HeV) and Nipah virus (NiV) are the causative agents of emerging transboundary animal disease in pigs and horses. They also cause fatal disease in humans. NiV has a case fatality rate of 40 - 100%. In the initial NiV outbreak in Malaysia in 1999, about 1.1 million pigs had to be culled. The economic impact was estimated to be approximately
A, Tamin, P A, Rota
openaire   +2 more sources

Clinical and Pathological Manifestations of Human Henipavirus Infection

2012
The clinicopathological features of human Nipah virus and Hendra virus infections appear to be similar. The clinical manifestations may be mild, but if severe, includes acute encephalitic and pulmonary syndromes with a high mortality. The pathological features in human acute henipavirus infections comprise vasculopathy (vasculitis, endothelial ...
Wong, K.T., Tan, C.T.
openaire   +2 more sources

Henipavirus encephalitis

2014
Suhailah, Abdullah, Chong Tin, Tan
openaire   +2 more sources